BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gao L, Gu Y, Yin X. High Serum Tumor Necrosis Factor-Alpha Levels in Women with Polycystic Ovary Syndrome: A Meta-Analysis. PLoS One 2016;11:e0164021. [PMID: 27764100 DOI: 10.1371/journal.pone.0164021] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 5.4] [Reference Citation Analysis]
Number Citing Articles
1 Hu M, Zhang Y, Li X, Cui P, Sferruzzi-Perri AN, Brännström M, Shao LR, Billig H. TLR4-Associated IRF-7 and NFκB Signaling Act as a Molecular Link Between Androgen and Metformin Activities and Cytokine Synthesis in the PCOS Endometrium. J Clin Endocrinol Metab 2021;106:1022-40. [PMID: 33382900 DOI: 10.1210/clinem/dgaa951] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Chien YJ, Chang CY, Wu MY, Chen CH, Horng YS, Wu HC. Effects of Curcumin on Glycemic Control and Lipid Profile in Polycystic Ovary Syndrome: Systematic Review with Meta-Analysis and Trial Sequential Analysis. Nutrients 2021;13:684. [PMID: 33669954 DOI: 10.3390/nu13020684] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
3 Alivandi Farkhad S, Khazali H. Therapeutic effects of isoflavone-aglycone fraction from soybean (Glycine max L. Merrill) in rats with estradiol valerate-induced polycystic ovary syndrome as an inflammatory state. Gynecol Endocrinol 2019;35:1078-83. [PMID: 31185755 DOI: 10.1080/09513590.2019.1624715] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
4 Liu Q, Xie YJ, Qu LH, Zhang MX, Mo ZC. Dyslipidemia involvement in the development of polycystic ovary syndrome. Taiwan J Obstet Gynecol 2019;58:447-53. [PMID: 31307731 DOI: 10.1016/j.tjog.2019.05.003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 11.0] [Reference Citation Analysis]
5 Moulana M. Immunophenotypic profile of leukocytes in hyperandrogenemic female rat an animal model of polycystic ovary syndrome. Life Sci 2019;220:44-9. [PMID: 30708097 DOI: 10.1016/j.lfs.2019.01.048] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
6 Raeisi T, Rezaie H, Darand M, Taheri A, Garousi N, Razi B, Roever L, Mohseni R, Hussien Mohammed S, Alizadeh S. Circulating resistin and follistatin levels in obese and non-obese women with polycystic ovary syndrome: A systematic review and meta-analysis. PLoS One 2021;16:e0246200. [PMID: 33740002 DOI: 10.1371/journal.pone.0246200] [Reference Citation Analysis]
7 Abuelezz NZ, Shabana ME, Abdel-Mageed HM, Rashed L, Morcos GNB. Nanocurcumin alleviates insulin resistance and pancreatic deficits in polycystic ovary syndrome rats: Insights on PI3K/AkT/mTOR and TNF-α modulations. Life Sci 2020;256:118003. [PMID: 32589998 DOI: 10.1016/j.lfs.2020.118003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
8 Herman R, Jensterle M, Janež A, Goričar K, Dolžan V. Genetic Variability in Antioxidative and Inflammatory Pathways Modifies the Risk for PCOS and Influences Metabolic Profile of the Syndrome. Metabolites 2020;10:E439. [PMID: 33138337 DOI: 10.3390/metabo10110439] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
9 Juan CC, Chen KH, Chen CW, Ho CH, Wang PH, Chen HS, Hwang JL, Lin YH, Seow KM. Increased regulated on activation, normal T-cell expressed and secreted levels and cysteine-cysteine chemokine receptor 5 upregulation in omental adipose tissue and peripheral blood mononuclear cells are associated with testosterone level and insulin resistance in polycystic ovary syndrome. Fertil Steril 2021:S0015-0282(21)00446-5. [PMID: 34119324 DOI: 10.1016/j.fertnstert.2021.05.093] [Reference Citation Analysis]
10 Choudhary N, Choudhary S, Kumar A, Singh V. Deciphering the multi-scale mechanisms of Tephrosia purpurea against polycystic ovarian syndrome (PCOS) and its major psychiatric comorbidities: Studies from network pharmacological perspective. Gene 2021;773:145385. [PMID: 33383117 DOI: 10.1016/j.gene.2020.145385] [Reference Citation Analysis]
11 Khalafi M, Symonds ME. The impact of high‐intensity interval training on inflammatory markers in metabolic disorders: A meta‐analysis. Scand J Med Sci Sports 2020;30:2020-36. [DOI: 10.1111/sms.13754] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
12 Stokkeland LMT, Giskeødegård GF, Ryssdal M, Jarmund AH, Steinkjer B, Madssen TS, Stafne SN, Stridsklev S, Løvvik TS, Iversen AC, Vanky E. Changes in serum cytokines throughout pregnancy in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2021:dgab684. [PMID: 34529073 DOI: 10.1210/clinem/dgab684] [Reference Citation Analysis]
13 Schiffer L, Kempegowda P, Arlt W, O'Reilly MW. MECHANISMS IN ENDOCRINOLOGY: The sexually dimorphic role of androgens in human metabolic disease. Eur J Endocrinol 2017;177:R125-43. [PMID: 28566439 DOI: 10.1530/EJE-17-0124] [Cited by in Crossref: 50] [Cited by in F6Publishing: 28] [Article Influence: 12.5] [Reference Citation Analysis]
14 Tanaka K, Nakabayashi K, Kawai T, Tanigaki S, Matsumoto K, Hata K, Kobayashi Y. Gene expression and DNA methylation changes in BeWo cells dependent on tumor necrosis factor-α and insulin-like growth factor-I. Hum Cell 2020;33:37-46. [PMID: 31724103 DOI: 10.1007/s13577-019-00299-5] [Reference Citation Analysis]
15 Delitala AP, Capobianco G, Delitala G, Cherchi PL, Dessole S. Polycystic ovary syndrome, adipose tissue and metabolic syndrome. Arch Gynecol Obstet 2017;296:405-19. [DOI: 10.1007/s00404-017-4429-2] [Cited by in Crossref: 52] [Cited by in F6Publishing: 42] [Article Influence: 13.0] [Reference Citation Analysis]
16 Lang Q, Yidong X, Xueguang Z, Sixian W, Wenming X, Tao Z. ETA-mediated anti-TNF-α therapy ameliorates the phenotype of PCOS model induced by letrozole. PLoS One 2019;14:e0217495. [PMID: 31170164 DOI: 10.1371/journal.pone.0217495] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
17 Helal BAF, Ismail GM, Nassar SE, Zeid AAA. Effect of vitamin D on experimental model of polycystic ovary syndrome in female rats. Life Sci 2021;283:119558. [PMID: 33930367 DOI: 10.1016/j.lfs.2021.119558] [Reference Citation Analysis]
18 Xie Q, Xiong X, Xiao N, He K, Chen M, Peng J, Su X, Mei H, Dai Y, Wei D, Lin G, Cheng L. Mesenchymal Stem Cells Alleviate DHEA-Induced Polycystic Ovary Syndrome (PCOS) by Inhibiting Inflammation in Mice. Stem Cells Int 2019;2019:9782373. [PMID: 31611920 DOI: 10.1155/2019/9782373] [Cited by in Crossref: 8] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
19 Ciebiera M, Włodarczyk M, Zgliczyńska M, Łukaszuk K, Męczekalski B, Kobierzycki C, Łoziński T, Jakiel G. The Role of Tumor Necrosis Factor α in the Biology of Uterine Fibroids and the Related Symptoms. Int J Mol Sci 2018;19:E3869. [PMID: 30518097 DOI: 10.3390/ijms19123869] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 7.0] [Reference Citation Analysis]
20 Sagvekar P, Kumar P, Mangoli V, Desai S, Mukherjee S. DNA methylome profiling of granulosa cells reveals altered methylation in genes regulating vital ovarian functions in polycystic ovary syndrome. Clin Epigenetics 2019;11:61. [PMID: 30975191 DOI: 10.1186/s13148-019-0657-6] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 13.5] [Reference Citation Analysis]